Tirzepatide, a dual receptor agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, enhances β-cell survival and maintenance markers in obese diabetic ovariectomized mice.

Published in: Diabetes, obesity & metabolism (2024)

Keyphrases